TOKYO -- University of Tokyo scientists have devised a way to generate liver cells using stem cells at roughly half the cost of a conventional technique, possibly paving the way for speedier drug development.
The group led by professor Atsushi Miyajima used induced pluripotent stem (iPS) cells to grow liver progenitor cells, or intermediate cells that have yet to mature into full-blown adult cells.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.